Subcutaneous Insulin Safely Treats DKA, Keeps Patients From ICU

Despite recommendations, standard treatment of patients with diabetes who experience diabetic ketoacidosis at US hospitals continues to be intravenous insulin in ICUs.
Medscape Medical News